Probiotics: Delineation of Prophylactic and Therapeutic Benefits

다국어 초록 (Multilingual Abstract)

Probiotics produce a beneficial impact on the host by improving the endogenous flora. It has been advocated that nonpathogenic bacteria like Lactobacillus and Bifidobacterium may undergo antagonistic interactions with other bacterial strains and can be used to control pathogenic bacteria. Novel modes of therapeutic and prophylactic interventions are based on their consumption either alone or in combination with prebiotics. Usefulness of probiotics has been implicated in allergies, cancer, AIDS, and respiratory and urinary tract infections. In this review we have listed various findings suggesting their benefits in alleviating symptoms associated with aging, fatigue, and autism. Newer claims indicating their role in reducing the risks of osteoporosis, obesity, and possibly type 2 diabetes are also discussed. Considering the wide array of such activities, the present review comprehensively elaborates upon the proposed benefits of probiotics. The concept of synbiotics, a combination of probiotics and prebiotics beneficially affecting the survival and implantation of such live organisms, is also discussed. Available probiotic strains, their commercial preparations, and newer approaches to improve the efficacy and overcome limitations of the therapy are also discussed in relation to the future of probiotic therapy. Considering that the purported claims about disease risk reduction are tentative, the review also encompasses various aspects regarding the safety of probiotics and their possible future role in disease prevention.

참고문헌 (Reference)

1 Boudraa G, 307-313, 2001

2 Wenus C, 299-301, 2008

3 Hilton E, "fficacy of LactobacillusGG as a diarrhoeal preventive in travellers" 41-43, 1997

4 Cauci S, "Vaginal hydrolytic enzymes, immunoglobulinA against Gardnerella vaginalis toxin, and risk ofearly preterm birth among women in preterm labor with bacterialvaginosis or intermediate flora" 877-881, 2002

5 Delia P, "Use of probiotics for preventionof radiation-induced diarrhea" 912-915, 2007

6 Lieske JC, "Use of a probioticto decrease enteric hyperoxaluria" 1244-1249, 2005

7 Reid G, "Urogenital Microflora and Urinary TractInfections" Kluwe 1998

8 Astegiano M, "Treatment of irritable bowel syndrome. A case control experience" 349-358, 2006

9 Scholmerich J, "Treatment of inflammatory bowel disease" 337-343, 2007

10 Hallén A, "Treatment of bacterial vaginaldisease with lactobacilli" 148-, 1992

11 Szymanski H, "Treatment of acute infectious diarrhoea in infantsand children with a mixture of three Lactobacillus rhamnosusstrains—a randomized, double-blind, placebo-controlled trial" 247-253, 2006

12 Koch S, "Treatment and prevention ofenterococcal infections—alternative and experimental approaches" 1519-1531, 2004

13 Bergogne-Berezin E, "Treatment and prevention of antibioticassociated diarrhoea" 16 : 521-526, 2000

14 Larsen CS, "Traveller’s diarrhea" 167 : 4068-4072, 2005

15 Prakash S, "Toward a new generation of therapeutics:artificial cell targeted delivery of live cells for therapy" 1-22, 2006

16 Feleszko W, "Toll-like receptors—novel targets in allergic airway disease (probiotics, friends andrelatives)" 308-318, 2006

17 Parent D, "Therapy of bacterial vaginosisusing exogenously-applied Lactobacillus acidophili and a lowdose of estriol: a placebo-controlled multicentric clinical trial" 68-73, 1996

18 Vandenbulcke L, "Theinnate immune system and its role in allergic disorders" 159-165, 2006

19 Rolfe RD, "The role of probiotic cultures in the control of gastrointestinalhealth" 396-402, 2000

20 Galdeano CM, "The probiotic bacterium Lactobacilluscasei induces activation of the gut mucosal immune systemthrough innate immunity" 219-226, 2006

21 Hoesl CE, "The probiotic approach: an alternativetreatment option in urology" 288-296, 2005

22 Hoesl CE, "The probiotic approach: an alternativetreatment option in urology" 288-296, 2005

23 Reid G, "The potential for probiotics to prevent bacterialvaginosis and preterm labor" 1202-1208, 2003

24 Goldin BR, "The effect of LactobacillusGG on the initiation and promotion of dimethyl-hydrazine inducedintestinal tumours in the rat" 197-204, 1996

25 Born P, "The Saccharomycesboulardii therapy of HIV-associated diarrhoea [letter" 765-, 1993

26 Morata de Ambrosini V, "Study of the morphology of the cell walls of somestrains of lactic acid bacteria and related species" 557-562, 1998

27 Maassen CB, "Strain-dependentinduction of cytokine profiles in the gut by orally administeredLactobacillus strains" 2613-2623, 2000

28 Moore WEC, "Some current conceptsin intestinal bacteriology" 33-42, 1978

29 Kayser FH, "Safety aspects of enterococci from the medical pointof view" 255-262, 2003

30 Bleichner G, "Saccharomycesboulardii prevents diarrhoea in critically ill tube-fed patients. Amulti-centre randomized, double-blind placebo-controlled trial" 517-523, 1997

31 Buts J-P, "Saccharomycesboulardii enhances rat intestinal enzyme expression by endoluminalrelease of polyamines" 522-527, 1994

32 Pothoulakis C, "Saccharomyces boulardiiinhibits Clostridium difficile toxin a binding and enterotoxicityin rat ileum" 1108-1115, 1993

33 Urbancsek H, "Results of a double-blind, randomized study to evaluate the efficacy and safetyof Antibiophilus in patients with radiation-induced diarrhoea" 391-396, 2001

34 "Report of a Joint FAO/WHO Expert Consultation on Evaluationof Health and Nutritional Properties of Probiotics in Food IncludingPowder Milk with Live Lactic Acid Bacteria" WorldHealth Organization & Food and Agricultural Organization ofthe United Nations 2001

35 Hauth JC, "Reduced incidence of preterm delivery with metronidazoleand erythromycin in women with bacterial vaginosis" 1732-1736, 1995

36 Wollowski I, "Protective role ofprobiotics and prebiotics in colon cancer" 451-455, 2001

37 Koop-Hooliham L:, "Prophylactic and therapeutic uses of probiotics:a review" 229-237, 2001

38 Morotomi M, "Properties of Lactobacillus casei Shirota strain asprobiotics" 29-30, 1996

39 Miettinen M, "Production of humannecrosis factor alpha, IL-6, and IL-10 is induced by lacticacid bacteria" 5403-5405, 1996

40 Doron S, "Probiotics: their role in the treatment and prevention of disease" 4 : 261-275, 2006

41 Lilly DM, "Probiotics: growth promoting factorsproduced by microorganisms" 747-748, 1965

42 Lilly DM, "Probiotics: growth promoting factorsproduced by microorganisms" 747-748, 1965

43 Caramia G, "Probiotics: from Metchnikoff to the current preventiveand therapeutic possibilities" 19-33, 2004

44 O’Sullivan GC, "Probiotics: an emergingtherapy" 3-10, 2005

45 Cummings JH, "Probiotics, prebiotics and antibioticsin inflammatory bowel disease" 99-111, 2004

46 O’Mahony L, "Probiotics, mononuclearcells and epithelial cells: an anti-inflammatory network [abstract].Gastroenterology 2000;118:A680.32. de Vrese M, Marteau PR: Probiotics and prebiotics: effects ondiarrhea" 803-811, 2007

47 Surawicz CM, "Probiotics, antibiotic-associated diarrhoea andClostridium difficile diarrhoea in humans" 775-783, 2003

48 Henriksson A, "Probiotics under the regulatory microscope" 4 : 1135-1143, 2005

49 Reid G, "Probiotics to prevent urinary tract infections:the rationale and evidence" 1-5, 2005

50 Kaur IP, "Probiotics potential pharmaceuticalapplications" 1-9, 2002

51 Mack DR, "Probiotics inhibit enteropathogenic E. coli adherence in vitro byinducing intestinal mucin gene expression" 941-950, 1999

52 Howard JC, "Probiotics in surgical wound infections:current status" 274-281, 2004

53 Sand J, "Probiotics in severe acute pancreatitis" 634-635, 2008

54 D’Souza AL RC, "Probiotics in preventionof antibiotic associated diarrhoea: meta-analysis" 1361-, 2002

55 Kaur IP, "Probiotics in paediatric disorders.Gut flora, potential agents and the road ahead" 20 : 37-48, 2006

56 Fuller R, "Probiotics in man and animals" 365-378, 1989

57 Fuller R, "Probiotics in man and animals" 365-378, 1989

58 Markowitz JE, "Probiotics in health and disease inthe pediatric patients" 127-141, 2002

59 Chermesh I, "Probiotics and the gastrointestinal tract:where we are in 2005?" 853-857, 2006

60 Broussard EK, "Probiotics and prebiotics in clinicalpractice" 104-113, 2004

61 Li Z, "Probiotics and antibodies to TNF inhibitinflammatory activity and improve nonalcoholic fatty liver disease" 343-350, 2003

62 Furrie E, "Probiotics and allergy" 465-469, 2005

63 Marteau P, "Probiotics" Chapman & Hall, London 65-68, 1997

64 Heyman M, "Probiotic microorganisms: how they affectintestinal pathophysiology" 1151-1165, 2002

65 Sheil B, "Probiotic effects on inflammatorybowel disease" 819-824, 2007

66 Saarela M, "Probiotic bacteria: safety, functional and technological properties" 197-215, 2000

67 Agostoni C, "Probiotic bacteria indietetic products for infants: a commentary by the ESPGHANCommittee on Nutrition" 365-374, 2004

68 Madsen K, "Probiotic bacteria enhancesmurine and human intestinal epithelial barrier function" 580-591, 2001

69 Reid G, "Probiotic agents to protect the urogenital tract infection" 437-444, 2001

70 Bayona Gonzalez A, "Preventionof caries with Lactobacillus (final results of a clinicaltrial on dental caries with killed Lactobacillus [Streptococcusand Lactobacillus] given orally)" 37-46, 1990

71 McFarland LV, "Prevention ofbeta-lactam associated diarrhoea by Saccharomyces boulardiicompared with placebo" 439-448, 1995

72 Tempe JD, "Prevention of diarrhoea administering Saccharomycesboulardii during continuous enteral feeding" 1409-1412, 1983

73 Scholz-Ahrens KE, "Prebiotics, probiotics,and synbiotics affect mineral absorption, bone mineral content,and bone structure" 838-846, 2007

74 Meier R, "Pre- and probiotics" 161-169, 2007

75 Penner RM, "Postoperative Crohn’sdisease" 11 : 765-777, 2005

76 Shanahan F, "Physiological basis for novel drug therapies usedto treat the inflammatory bowel diseases. I. Pathophysiologicalbasis and prospects for probiotic therapy in inflammatory boweldisease" 417-421, 2005

77 Surowiec D, "Past, present,and future therapies for Clostridium difficile-associated disease" 2155-2163, 2006

78 Kalliomaki M, "Pandemic of atopic diseases—a lackof microbial exposure in early infancy?" 193-199, 2002

79 Weiner HL, "Oral tolerance: immune mechanisms and treatmentof autoimmune diseases" 335-343, 1997

80 Kim N, "Oral feedingof Bifidobacterium bifidum (BGN4) prevents CD4" 30-39, 2007

81 Gardiner G, "Oral administration ofthe probiotic combination Lactobacillus rhamnosus GR-1 and L.fermentum RC-14 for human intestinal applications" 12 : 191-196, 2002

82 Schultz M, "Oral administration of Lactobacillus GG induces an anti-inflammatory,Th-2 mediated systemic immune response towardsintestinal organisms [abstract]" 4180-, 2000

83 Van den Heuvel E, "Oligofructose stimulates calcium absorption in adolescent" 544-548, 1999

84 Ericsson CD, "Nonantimicrobial agents in the prevention andtreatment of traveler’s diarrhoea" 557-563, 2005

85 Reid G, "New specific paradigms for probioticsand prebiotics" 105-118, 2003

86 Ogawa T, "Natural killer cell activitiesof synbiotic Lactobacillus casei ssp. casei in conjunction withdextran" 103-109, 2006

87 Grangette C, "Mucosal immune responses and protectionagainst tetanus toxin after intranasal immunization withrecombinant Lactobacillus plantarum" 1547-1553, 2001

88 Xavier RJ, "Microbiology: how to get along—friendly microbes in a hostile world" 1483-1484, 2000

89 Rook GA, "Microbes, immunoregulation, and the gut" 54 : 317-320, 2005

90 Tong JL, "Meta-analysis:the effect of supplementation with probiotics on eradication ratesand adverse events during Helicobacter pylori eradication therapy" 155-168, 2007

91 McFarland LV, "Meta-analysis of probiotics for the preventionof traveler’s diarrhea" 5 : 97-105, 2007

92 Fasano A, "Mechanisms of disease: the role ofintestinal barrier function in the pathogenesis of gastrointestinalautoimmune diseases" 416-422, 2005

93 O’Hara AM, "Mechanisms of action of probioticsin intestinal diseases" 31-46, 2007

94 Vesterlund S, "Measurement ofbacterial adhesion—in vitro evaluation of different methods" 225-233, 2005

95 Montalto M, "Management and treatmentof lactose malabsorption" 187-191, 2006

96 Logan AC, "Major depressive disorder: probioticsmay be an adjuvant therapy" 533-538, 2005

97 Manuel Y, "Magnesium status and parametersof the oxidant-antioxidant balance in patients withchronic fatigue syndrome: effects of supplementation with magnesium" 374-382, 2000

98 Tursi A, "Low-dose balsalazide plus a high-potency probioticpreparation is more effective than balsalazide alone ormesalazine in the treatment of acute mild-to-moderate ulcerativecolitis" 126-131, 2004

99 Reid G, "Low vaginal pH and urinary tract infection" 1704-, 1995

100 Savaiano DA, "Lactosemalabsorption from yoghurt, pasteurised yoghurt, sweet acidophilusmilk, and cultured milk in lactase deficient individuals" 1219-1223, 1984

101 Gaon D, "Lactose digestion by milk fermented with Lactobacillus acidophilusand Lactobacillus casei of human origin" 237-242, 1995

102 Geier MS, "Lactobacillusfermentum BR11, a potential new probiotic, alleviates symptomsof colitis induced by dextran sulfate sodium (DSS) in rats" 267-274, 2007

103 Salminen MK, "Lactobacillusbacteremia, species identification, and antimicrobial susceptibilityof 85 blood isolates" 35-44, 2006

104 Cadieux P, "Lactobacillus strains andvaginal ecology" 1940-1941, 2002

105 Shida K, "Lactobacillus casei strain Shirota suppresses serum immunoglobulin E and immunoglobulinG1 responses and systemic anaphylaxis in a food allergy mode" 563-570, 2002

106 Dieleman LA, "Lactobacillus GG preventsrecurrence of colitis in HLA-B27 transgenic rats after antibiotictreatment" 370-376, 2003

107 Vanderhoof JA, "Lactobacillus GG in the prevention of antibioticassociateddiarrhea in children" 135 : 535-537, 1999

108 Majamaa H, "Lactic acid bacteriain the treatment of acute rotavirus gastroenteritis" 333-338, 1995

109 Jauhiainen T, "Korpela R: Milk peptides and blood pressure" 825-829, 2007

110 "Joint FAO/WHO Working Group Report on Drafting Guidelinesfor the Evaluation of Probiotics in Food" World Health Organization& Food and Agricultural Organization of the United Nations 2002

111 Sheil B, "Is the mucosal route administrationessential for probiotic function? Subcutaneous administrationis associated with murine colitis and arthritis" 694-700, 2004

112 Gupta P, "Is LactobacillusGG helpful in children with Crohn’s disease? Resultsof a preliminary, open-label study" 453-457], 2000

113 Harris LA, "Irritable bowel syndrome: new and emergingtherapies" 128-135, 2006

114 Tsugawa N, "Intestinal absorption of calciumfrom calcium ascorbate in rats" 30-36, 1999

115 Tomoda T, "Intestinal Candida overgrowthand Candida infection in patients with leukemia: effectof Bifidobacterium administration" 71-74, 1998

116 Cauci S, "Interrelationships of interleukin-8 with interleukin-1" 9 : 53-58, 2003

117 Madsen KL, "Interleukin-10 gene-deficient mice develop a primary intestinalpermeability defect in response to enteric microflora" 262-270, 1999

118 Valdez JC, "Interference of Lactobacillus plantarum with Pseudomonasaeruginosa in vitro and in infected burns: the potential use ofprobiotics in wound treatment" 472-479, 2005

119 Marteau P, "Ineffectiveness of Lactobacillusjohnsonii la1 for prophylaxis of postoperative recurrence inCrohn’s disease: a randomised, double-blind, placebo-controlledgetaid trial" 443-454, 2005

120 Balcázar JL, "In vitro competitive adhesion and production of antagonisticcompounds by lactic acid bacteria against fishpathogens" 373-380, 2007

121 Bell SG, "Immunomodulation, part V: probiotics" 57-60, 2007

122 Reid G, "Identification and plasmidprofiles of Lactobacillus species from the vagina of 100 healthywomen" 23-26, 1996

123 Hepner G, "Hypocholesterolemiceffect of yoghurt and milk" 19-24, 1979

124 Niers LE, "Hoekstra MO:Probiotics for cow’s milk allergy: classification after intervention" 423-424, 2005

125 Matricardi PM, "High microbial turnover rate preventingatopy: a solution to inconsistencies impinging on the hygienehypothesis?" 1506-1510, 2000

126 Lesbros-Pantoflickova D, "Helicobacterpylori and probiotics" 812-818, 2007

127 Bischoff S, "Food allergy and the gastrointestinal tract" 20 : 156-161, 2004

128 Saavedra JM, "Feeding of Bifidobacterium bifidum and Streptococcus thermophilusto infants in hospital for prevention of diarrhoea andshedding of rotavirus" 1046-1049, 1994

129 Felley CP, "Favourableeffect of an acidified milk (LC-1) on Helicobacter pylori gastritisin man" 25-29, 2001

130 Butt HL, "Faecal microbial growthinhibition in chronic fatigue/pain patients [abstract]" 1998

131 Ulisse S, "Expression of cytokines, induciblenitric oxide synthase, and matrix metalloproteinases inpouchitis. Effects of probiotic treatment" 2691-2699, 2001

132 Hillier SL, "Eschenbach DA:The normal vaginal flora, H2O2-producing lactobacilli and bacterialvaginosis in pregnant woman" 273-281, 1993

133 Harms HK, "Enzyme substitutiontherapy with the yeast Saccharomyces cerevisiae in congenitalsucrase isomaltase deficiency" 1306-1309, 1987

134 Kaur IP, "Entrapment of probioticbacteria within alginate HPMC floating beads, their survivaland effectiveness against ethanol-induced ulcers in rats" 141-148, 2007

135 Koch S, "Enterococcal infections:host response, therapeutic, and prophylactic possibilities" 822-830, 2005

136 Kaila M, "Enhancement of the circulating antibody secreting cell responsein human diarrhoea by a human Lactobacillus strain" 141-144, 1992

137 Saint-Marc T, "Efficacy of Saccharomycesboulardii in the treatment of diarrhoea in aids [letter]" 64-65, 1991

138 Demirer S, "Effects of probiotics onradiation-induced intestinal injury in rats" 179-186, 2006

139 Aihara K, "Effectof powdered fermented milk with Lactobacillus helveticuson subjects with high-normal blood pressure or mild hypertension" 257-265, 2005

140 Michetti P, "Effect of whey-basedculture supernatant of Lactobacillus acidophilus (johnsonii) La1on Helicobacter pylori infection in humans" 203-209, 1999

141 Madden JA, "Effect of probiotics on preventingdisruption of the intestinal microflora following antibiotictherapy: a double-blind, placebo-controlled pilot study" 5 : 1091-1097, 2005

142 Andersson H, "Effect of low-fatmilk and fermented low-fat milk on cholesterol absorption andexcretion in ileostomy subjects" 274-281, 1995

143 Hatakka K, "Effect of long term consumptionof probiotic milk on infections in children attendingday care centres: double-blind, randomized trial" 1327-1329, 2001

144 Colecchia A, "Effect of a symbiotic preparation on the clinical manifestationsof irritable bowel syndrome, constipation-variant. Resultsof an open, uncontrolled multicenter study" 359-363, 2006

145 Kruis W, "Double-blind comparison of an oral E. coli preparation andmesalazine in maintaining remission of ulcerative colitis" 853-858, 1997

146 Noverr MC, "Does the microbiota regulate immuneresponses outside the gut?" 562-568, 2004

147 Vesa TH, "Digestion and tolerance of lactose from yoghurt and differentsemi-solid fermented dairy products containing Lactobacillusacidophilus and bifidobacteria in lactose maldigesters—is bacteriallactase important?" 730-733, 1996

148 Rafter J, "Dietary synbiotics reducecancer risk factors in polypectomized and colon cancer patients" 488-496, 2007

149 Ludwig DS, "Dietary fiber, weightgain and cardiovascular disease risk factors in young adults: theCARDIA Study" 1539-1546, 1999

150 Cauci S, "Determination of immunoglobulinA against Gardnerella vaginalis hemolysin, sialidaseand prolidase activities ion vaginal fluid: implications foradverse pregnancy outcomes" 435-438, 2003

151 Paton AW, "Designer probiotics for preventionof enteric infection" 193-200, 2006

152 Baumgart DC, "Current biological therapies for inflammatorybowel disease" 4127-4147, 2004

153 Klebanoff SJ, "Control of the microbial flora of vagina by H2O2-generating lactobacilli" 94-110, 1991

154 He F, "Comparison of mucosal adhesion and species identificationof Bifidobacterium isolated from healthy and allergic infants" 30 : 43-47, 2001

155 Campieri M, "Combination of antibioticand probiotic treatment is efficacious in prophylaxis of post-operativerecurrence of Crohn’s disease: a randomized controlledstudy vs. mesalamine [abstract]" 4179-, 2000

156 Posani T, "Clostridium difficile: causes and interventions" 547-551, 2004

157 Anukam KC, "Clinical study comparing probiotic Lactobacillus GR-1and RC-14 with metronidazole vaginal gel to treat symptomaticbacterial vaginosis" 2772-2776, 2006

158 De Smet I, "Cholesterol lowering inpigs through enhanced bacterial bile salt hydrolase activity" 185-194, 1998

159 Nguyen TD, "Characterization of Lactobacillusplantarum PH04, a potential probiotic bacterium with cholesterol-lowering effects" 358-361, 2007

160 Gonzalez SN, "Biotherapeuticrole of fermented milk" 129-134, 1994

161 Weaver CM, "Biomarkers of bone health appropriatefor evaluating functional foods designed to reduce risk of osteoporosis" 88 : 225-232, 2002

162 Hill JO, "Biomarkers and functional foods for obesityand diabetes" 213-218, 2002

163 Sanfilippo L, "Bacteroides fragilis enterotoxin induces the expression ofIL-8 and transforming growth factor-beta (TFG-" 456-463, 2000

164 Anukam K, "Augmentation of antimicrobialmetronidazole therapy of bacterial vaginosis withoral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillusreuteri RC-14: randomized, double-blind, placebo controlledtrial" 1450-1454, 2006

165 Ockerman P, "Antioxidant treatment of chronic fatigue syndrome" 88-91, 2000

166 Manuel Y, "Antioxidant status andlipoprotein peroxidation of chronic fatigue syndrome" 2037-2049, 2001

167 Asahara T, "Antimicrobialactivity of interurethrally administered probiotic Lactobacilluscasei in a murine model of Escherichia coli urinary tractinfection" 1751-1760, 2001

168 Yadav H, "Antidiabetic effect of probiotic dahicontaining Lactobacillus acidophilus and Lactobacillus casei inhigh fructose fed rats" 62-68, 2007

169 Schroder O, "Antibiotic-associated diarrhea" 193-204, 2006

170 Gollop N, "Antibacterial activity of lacticacid bacteria included in inoculants for silage and in silagestreated with these inoculants" 662-666, 2005

171 Komaroff AL, "An examination of workingcase definition of chronic fatigue syndrome" 56-64, 1996

172 Isolauri E, "Ahuman Lactobacillus strain (L. casei sp. strain GG) promotes recoveryfrom acute diarrhoea in children" 90-97, 1991

173 Vizoso Pinto MG, "Adhesive and chemokine stimulatory propertiesof potentially probiotic Lactobacillus strains" 125-134, 2007

174 Haller D, "Activationof human peripheral blood mononuclear cells by nonpathogenicbacteria in vitro: evidence of NK cells as primary targets" 752-759, 2000

175 Liong MT, "Acid and bile tolerance and cholesterol removalability of lactobacilli strains" 55-66, 2005

176 McFarland LV, "A randomizedplacebo controlled trial of Saccharomyces boulardii in combinationwith standard antibiotics for Clostridium difficile disease" 1913-1918, 1994

177 Fan YJ, "A probiotic treatmentcontaining Lactobacillus, Bifidobacterium and Enterococcus improvesIBS symptoms in an open label trial" 987-991, 2006